EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life

Siberyn T Nuijens iD, Lisa M C van Hoogstraten iD, Noëlle B Terpstra, Ivy Beeren iD, Alina Vrieling iD, Eveline M Wijnen, Richard P Meijer, Lambertus A Kiemeney, J Alfred Witjes, Katja K H Aben

BJU International · 2025-10 · 136 (4) · 657-668

DOI: 10.1111/bju.16736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 16.04.2025. Verfasst von Siberyn T Nuijens und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Urinary Bladder Neoplasms, Cystectomy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the impact of treatment for localised muscle‐invasive bladder cancer (MIBC) during the first 2 years after diagnosis. Patients and Methods A prospective cohort study was conducted including patients diagnosed with non‐metastatic (cM0) MIBC between November 2017 and November 2019 in the Netherlands. Health‐related quality of life (HRQoL) was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30) as well as the MIBC‐specific QLQ‐BLM30 module. Questionnaires were administered at baseline (pre‐treatment) and at 6, 12 and 24 months after diagnosis. Patients were grouped by treatment: neoadjuvant chemotherapy (NAC) and radical cystectomy (RC), upfront RC, chemoradiation, and radiotherapy. Linear mixed models were used to assess HRQoL changes over time per treatment group.

Results

A total of 518 patients participated in quality of life measurements (46% response rate). After excluding 14 patients who did not complete the EORTC QLQ‐C30 and 114 for baseline completion after start of treatment, a total of 390 patients were included of whom 105 underwent NAC and RC, 148 underwent upfront RC, 58 underwent chemoradiation, and 79 underwent radiotherapy alone. Over time, clinically relevant improvements in emotional functioning and future perspective were observed across all treatment groups. However, a temporary worsening in physical functioning was observed at 6 months. Patients treated with RC (with or without NAC) experienced persistent deteriorations in body image and sexual functioning up to at least 2 years after diagnosis, although urostomy‐related outcomes improved. Patients undergoing chemoradiation showed improvements in urinary symptoms, while those receiving radiotherapy reported significant worsening of dyspnoea over time.

Conclusion

In this largest population‐based study to date on HRQoL in MIBC, HRQoL largely recovered to baseline levels during the first 2 years after diagnosis. However, persistent deteriorations in physical and cognitive functioning, body image, and sexual function were observed, particularly in patients treated with RC (with or without NAC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeUrinary Bladder NeoplasmsCystectomyHumansMaleFemaleAgedProspective StudiesMiddle AgedNeoplasm InvasivenessNeoadjuvant TherapyNetherlandsAged, 80 and overSurveys and Questionnaires

Stichwörter der Autor:innen

EORTC QLQ‐BLM30EORTC QLQ‐C30chemoradiationhealth‐related quality of lifemuscle‐invasive bladder cancerneoadjuvant chemotherapypatient‐reported outcomesradical cystectomyradiotherapytrimodal therapy

Autor:innen und Institutionen

  • Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Siberyn T Nuijens, Lisa M C van Hoogstraten, Ivy Beeren, Alina Vrieling

Zitieren

APA

Nuijens, S. T., van Hoogstraten, L. M. C., Terpstra, N. B., Beeren, I., Vrieling, A., Wijnen, E. M., Meijer, R. P., Kiemeney, L. A., Witjes, J. A., & Aben, K. K. H. (2025). The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life. BJU International, 136(4), 657-668. https://doi.org/10.1111/bju.16736

Vancouver

Nuijens ST, van Hoogstraten LMC, Terpstra NB, Beeren I, Vrieling A, Wijnen EM, et al. The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life. BJU International. 2025;136(4):657-668. doi:10.1111/bju.16736

BibTeX
@article{Nuijens2025,
  author = {Nuijens, Siberyn T and van Hoogstraten, Lisa M C and Terpstra, Noëlle B and Beeren, Ivy and Vrieling, Alina and Wijnen, Eveline M and Meijer, Richard P and Kiemeney, Lambertus A and Witjes, J Alfred and Aben, Katja K H},
  title = {The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life},
  journal = {BJU International},
  year = {2025},
  volume = {136},
  number = {4},
  pages = {657--668},
  doi = {10.1111/bju.16736}
}
Kostenlos starten →